Clinical Trials Logo

Citation(s)

  •   Cayirli M, Caliskan E, Açikgöz G, Erbil AH, Ertürk G
    Regression of melasma with platelet-rich plasma treatment. Ann Dermatol. 2014 Jun;26(3):401-2. doi: 10.5021/ad.2014.26.3.401. Epub 2014 Jun 12.
  •   Grimes PE
    Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995 Dec;131(12):1453-7. Review.
  •   Kim DS, Park SH, Park KC
    Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int J Biochem Cell Biol. 2004 Aug;36(8):1482-91.

Evaluation of the Therapeutic Effect of Platelet Rich Plasma in Melasma

Details for clinical trial NCT03308370